BERG Teams with Icahn School to Develop Potential Therapeutics for Cancer, Other Diseases

BERG and the Icahn School of Medicine at Mount Sinai have engaged in a research and development partnership to to obtain novel insights and potential therapeutics for cancer, central nervous system and endocrine disorders.

The partnership will leverage BERG’s Interrogative Biology® platform in combination with Mount Sinai’s expertise in big data, advanced analytics and biological network modeling.